Evidence map›Paper›PMID 26913967›Full record

ArticleElectrophoresis2016

Reliable LC-MS quantitative glycomics using iGlycoMab stable isotope labeled glycans as internal standards.

Shiyue Zhou, Nadia Tello, Alex Harvey, Barry Boyes, Ron Orlando, Yehia Mechref

Abstract read
In one paragraph

Article in Electrophoresis, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. The Role of Clinical Glyco(proteo)mics in Precision Medicine.Molecular & cellular proteomics : MCP · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. 8-plex LC-MS/MS Analysis of PermethylatedAnalytical chemistry · 2019
    Article
  8. Clinical glycomics in the diagnostic laboratory.Annals of translational medicine · 2019
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shiyue ZhouDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX, USA.
Nadia TelloDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX, USA.
Alex HarveyGlycoScientific, Athens, GA, USA.
Barry BoyesGlycoScientific, Athens, GA, USA.
Ron OrlandoGlycoScientific, Athens, GA, USA.
Yehia MechrefDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX, USA.

Funding

Sensitive and Quantitative MS-bases Glycomic Mapping PlatformR01GM112490 · NIGMS · TEXAS TECH UNIVERSITY · PI MECHREF, YEHIA · 2014 to 2024
$3.2M
Development of Isotopically Labeled Glycoproteins for use as Internal StandardsR41GM113666 · NIGMS · GLYCOSCIENTIFIC, LLC · PI ORLANDO, RON · 2015 to 2015
$270k
NIGMS NIH HHS R01 GM112490NIGMS NIH HHS R41 GM113666
6 · The paper itself

Abstract

Glycans have numerous functions in various biological processes and participate in the progress of diseases. Reliable quantitative glycomic profiling techniques could contribute to the understanding of the biological functions of glycans, and lead to the discovery of potential glycan biomarkers for diseases. Although LC-MS is a powerful analytical tool for quantitative glycomics, the variation of ionization efficiency and MS intensity bias are influencing quantitation reliability. Internal standards can be utilized for glycomic quantitation by MS-based methods to reduce variability. In this study, we used stable isotope labeled IgG2b monoclonal antibody, iGlycoMab, as an internal standard to reduce potential for errors and to reduce variabililty due to sample digestion, derivatization, and fluctuation of nanoESI efficiency in the LC-MS analysis of permethylated N-glycans released from model glycoproteins, human blood serum, and breast cancer cell line. We observed an unanticipated degradation of isotope labeled glycans, tracked a source of such degradation, and optimized a sample preparation protocol to minimize degradation of the internal standard glycans. All results indicated the effectiveness of using iGlycoMab to minimize errors originating from sample handling and instruments.

Indexed as

Isotope LabelingCell Line, TumorChromatography, LiquidGlycomicsHumansMass SpectrometryPolysaccharidesReference StandardsPolysaccharidesGlycomicsiGlycoMAbInternal standardLC-MS/MSPermethylation

Identifiers

PMID26913967
PMCPMC4964797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.